A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS

by Berry, J.D, Brooks, L., Brunstein, F., Burgess, B.L, Cheeti, S., Chen, C., Cho, W., Couch, J.A, Cudkowicz, M.E, Galanter, J., Genge, A., Ghosh, A.S, Glass, J.D, Hains, A.B, Honigberg, L., Katz, J.S, Kerchner, G.A, Oskarsson, B., Rothenberg, M.E, Rothstein, J.D, Sharma, K.R, van den Berg, L., Yeh, F.L
Published 2022